2-amino-2-methylpropanenitrile

We are 2-amino-2-methylpropanenitrile CAS:19355-69-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-amino-2-methylpropanenitrile
CAS.NO:19355-69-2
Synonyms:2-amino-2-methylpropanenitrile
2-Cyanoisopropylamine
Propanenitrile,2-amino-2-methyl
2-methyl-2-aminopropionitrile
2-cyano-2-amino-propane
 
Physical and Chemical Properties:
Density 0.9±0.1 g/cm3
Boiling Point 150.4±23.0 °C at 760 mmHg
Molecular Formula C4H8N2
Molecular Weight 84.120
Flash Point 44.7±22.6 °C
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.0%
Moisture:≤0.5%
Melting point:145.0-155.0°C
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Raltegravir(CAS:518048-05-0) and Raltegravir potassium(CAS:871038-72-1).

2-amino-2-methylpropanenitrile


Related News: Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.6290-49-9 The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.2-bromo-5-methylpyridin-3-amine Retrogenix’s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses.4- (6-nitropiridin-3-il) piperazina-1-carboxilato de terc-butilo CAS:571189-16-7 ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States.“CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.

Related Products
Product Name
1-ethyl-4-(4-iodophenyl)benzene View Details
2-fluoro-4-iodopyridine View Details
4-Chloro-2,6-diaminopyrimidine View Details
2-[1-(Mercaptomethyl)Cyclopropyl]Acetic Acid manufacturer 1-Fluoro-6-iodohexane manufacturer 1,4-Bis(2-hydroxyethyl)piperazine manufacturer 3-(2-Methoxy-5-methylphenyl)-3-phenyl-propanoic Acid manufacturer T-butyl-(3R,5S)-6-hydroxy 3,5-O-isopropylidene 3,5-dihydroxyhexanoate manufacturer